Invacare Corporation (IVC): Price and Financial Metrics
Invacare Corporation (IVC)
Today's Latest Price: $7.45 USD
Updated Sep 28 7:00pm
Add IVC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 140 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
IVC Stock Summary
- Invacare Corp's stock had its IPO on March 26, 1990, making it an older stock than 84.63% of US equities in our set.
- With a price/sales ratio of 0.29, Invacare Corp has a higher such ratio than only 11.02% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, Invacare Corp is reporting a growth rate of 79.37%; that's higher than 86.57% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Invacare Corp are MTW, OSK, VRTU, BV, and AZZ.
- IVC's SEC filings can be seen here. And to visit Invacare Corp's official web site, go to www.invacare.com.
IVC Stock Price Chart Technical Analysis Charts
IVC Price/Volume Stats
| Current price | $7.45 | 52-week high | $11.63 |
| Prev. close | $7.40 | 52-week low | $3.90 |
| Day low | $7.36 | Volume | 418,834 |
| Day high | $7.65 | Avg. volume | 405,953 |
| 50-day MA | $7.01 | Dividend yield | N/A |
| 200-day MA | $7.26 | Market Cap | 256.42M |
Invacare Corporation (IVC) Company Bio
Invacare Corporation designs, manufactures, and distributes medical equipment and supplies used in the home and long-term care settings. It operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and Asia/Pacific. The company was founded in 1885 and is based in Elyria, Ohio.
IVC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $7.45 | $0.16 | -98% |
Below please find a table outlining a discounted cash flow forecast for IVC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Invacare Corp ranked in the 4th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Invacare Corp, consider:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 46. Its equity weight surpasses that of only 16.28% of free cash flow generating stocks in the Healthcare sector.
- Its compound free cash flow growth rate, as measured over the past 5.01 years, is -0.07% -- higher than only 16.29% of stocks in our DCF forecasting set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -98% |
| 1% | -98% |
| 2% | -98% |
| 3% | -98% |
| 4% | -98% |
| 5% | -98% |
FGEN, PHG, SSKN, ATRS, and CRY can be thought of as valuation peers to IVC, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...